Prostaglandin E2 Reverses Aberrant Production of an Inflammatory Chemokine by Microglia from Sandhoff Disease Model Mice through the cAMP-PKA Pathway

• Eri Kawashita,

  Affiliations Department of Medicinal Biotechnology, Institute for Medicinal Research, Graduate School of Pharmaceutical Sciences, The University of Tokushima, Tokushima, Japan, Department of Clinical Pathological Biochemistry, Faculty of Pharmaceutical Science, Doshisha Women's Collage of Liberal Arts, Kyoto, Japan

  ⨯
• Daisuke Tsuji,

  Affiliations Department of Medicinal Biotechnology, Institute for Medicinal Research, Graduate School of Pharmaceutical Sciences, The University of Tokushima, Tokushima, Japan, National Institute of Biomedical Innovation (NIBIO), Osaka, Japan

  ⨯
• Masahiro Toyoshima,

  Affiliation Department of Medicinal Biotechnology, Institute for Medicinal Research, Graduate School of Pharmaceutical Sciences, The University of Tokushima, Tokushima, Japan

  ⨯
• Yosuke Kanno,

  Affiliation Department of Clinical Pathological Biochemistry, Faculty of Pharmaceutical Science, Doshisha Women's Collage of Liberal Arts, Kyoto, Japan

  ⨯
• Hiroyuki Matsuno,

  Affiliation Department of Clinical Pathological Biochemistry, Faculty of Pharmaceutical Science, Doshisha Women's Collage of Liberal Arts, Kyoto, Japan

  ⨯
• Kohji Itoh

  * E-mail: kitoh@ph.tokushima-u.ac.jp

  Affiliations Department of Medicinal Biotechnology, Institute for Medicinal Research, Graduate School of Pharmaceutical Sciences, The University of Tokushima, Tokushima, Japan, National Institute of Biomedical Innovation (NIBIO), Osaka, Japan

  ⨯